Mode
Text Size
Log in / Sign up

Platelet-rich plasma shows potential for tissue repair and functional recovery in various nerve injuriesPlatelet-rich plasma shows potential for nerve and brain repair

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that while PRP shows promise in preclinical models for nerve repair, clinical translation requires more standardization.

This systematic review synthesizes preclinical evidence regarding the use of platelet-rich plasma (PRP) for treating various neurological conditions, including spinal cord injury, Alzheimer's disease, and peripheral nerve injuries (sciatic and facial). The review highlights that PRP releases growth factors such as IGF-1, PDGF, VEGF, and TGF-beta, while activating PI3K/Akt and MAPK/ERK signaling pathways.

In animal models, intrathecal PRP showed potential to alleviate neuroinflammation in spinal cord injuries. For Alzheimer's disease, intranasal administration was associated with improved cognitive function and neurogenesis. In peripheral nerve injuries, local injection or filling within nerve conduits significantly promoted regeneration and functional recovery. These findings suggest a theoretical basis for PRP in neural repair.

Several limitations are noted, including a lack of standardization, unclear mechanisms, and the need to verify long-term safety. Because the evidence is primarily preclinical, the clinical application of PRP is not yet established. The review serves as a reference for future research and clinical translation.

How this fits prior evidence

This systematic review addresses a gap in the treatment of neurodegenerative and nerve injuries by exploring the role of growth factors in tissue repair. While previous coverage noted that IL-34/CSF1R signaling modulates CNS immune cell development and impacts neurodegenerative disease progression, this review explores the specific mechanism of platelet-rich plasma in promoting neurogenesis and reducing neuroinflammation. It also provides a different approach to managing Alzheimer's disease compared to the use of excitatory rTMS for MMSE improvements.

Researchers reviewed the potential of platelet-rich plasma (PRP) to treat various nerve and brain conditions. This review looked at how PRP might help with spinal cord injuries, Alzheimer's disease, and facial or sciatic nerve injuries. The findings are based on animal models and laboratory studies, which are early stages of medical research.

In animal studies, PRP showed promise in several ways. For spinal cord injuries, it may help reduce inflammation. For Alzheimer's disease, it was shown to improve memory and brain cell growth when delivered through the nose. For facial and sciatic nerve injuries, local injections helped nerves regrow and function better. These improvements are linked to the release of specific growth factors and the activation of certain cellular pathways.

It is important to note that these results are currently limited to animal models and laboratory settings. There is not enough data yet to know how well this works in humans or if it is safe for long-term use. Because the treatment is not yet standardized, it is not currently a standard medical practice. You should talk to your doctor about any specific concerns regarding nerve or brain health.

What this means for you:
Early animal studies show PRP may help repair nerves and brain tissue, but human safety is not yet established.

Common questions

What conditions can platelet-rich plasma help with?

The review found that platelet-rich plasma (PRP) showed potential for treating spinal cord injuries, Alzheimer's disease, and peripheral nerve issues like facial and sciatic nerve injuries. These results were observed in animal models and laboratory settings to help with tissue repair and nerve regeneration.

Is platelet-rich plasma safe for human use right now?

It is not yet known if platelet-rich plasma is safe for long-term human use. The current evidence comes from animal models, and there is a lack of standardized protocols and long-term safety data for humans. You should consult a medical professional for any personal health concerns.

How does it work for nerve and brain damage?

In animal studies, PRP released growth factors and activated specific signaling pathways. This helped reduce inflammation in spinal cord injuries, promoted nerve growth in facial and sciatic nerves, and improved cognitive function and cell growth in models of Alzheimer's disease.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Platelet-rich plasma (PRP), an autologous blood derivative rich in multiple growth factors and cytokines, has shown broad application prospects in the field of tissue repair and regeneration. In recent years, the therapeutic potential of PRP in neurological disorders has gained increasing attention. This article systematically reviews the classification systems, preparation methods, and the molecular mechanisms and application progress of PRP in neural repair. In preclinical studies, PRP has been shown to release insulin-like growth factor-1 (IGF-1), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-β (TGF-β), which may synergistically activate PI3K/Akt and MAPK/ERK signaling pathways, suggesting potential tissue repair, axonal regenerative, angiogenic, and immunomodulatory effects. The three-dimensional fibrin scaffold formed upon platelet activation not only provides physical support for cell migration and axonal growth but also enables the sustained local release of growth factors. In central nervous system disorders, intrathecal PRP has shown potential in animal models to alleviate neuroinflammation after spinal cord injury(SCI), and intranasal administration can improve cognitive function and neurogenesis in Alzheimer’s disease(AD) models. In peripheral nervous system disorders, local injection or PRP filling within nerve conduits significantly promotes regeneration and functional recovery after injuries to the sciatic nerve, facial nerve, and others. Furthermore, the therapeutic efficacy of PRP is influenced by factors such as preparation method, cellular composition (leukocyte content), administration route, and activation method. Although preclinical evidence is substantial, the clinical application of PRP in neurological disorders still faces challenges including a lack of standardization, unclear mechanisms, and the need to verify long-term safety. This review aims to provide a theoretical basis and practical reference for further research and clinical translation of PRP in the field of neural repair.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.